Nuclear Medicine and Radiopharmaceutic Market Report

Europe Nuclear Medicine and Radiopharmaceutic Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 10, 2020
  • PAGES：201
  • REPORT CODE：GMM541625
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Nuclear Medicine and Radiopharmaceutic market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Nuclear Medicine and Radiopharmaceutic Market Segmentations:

    By Player:

    • Navidea

    • Bayer

    • Jubilant Pharma

    • Dongcheng

    • Nordion

    • Lantheus

    • Mallinckrodt

    • IBA Group

    • Eli Lilly

    • Triad Isotopes

    • Advanced Accelerator Applications

    • GE Healthcare

    • SIEMENS

    • Company

    • Bracco Imaging

    • China Isotope & Radiation

    By Type:

    • Diagnostic Radioisotopes

    • Therapeutic Radioisotopes

    By End-User:

    • Oncology

    • Cardiology

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine and Radiopharmaceutic Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes from 2014 to 2026

    • 1.3.2 Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Oncology from 2014 to 2026

    • 1.4.2 Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Cardiology from 2014 to 2026

    • 1.4.3 Europe Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Radioisotopes

      • 3.4.2 Market Size and Growth Rate of Therapeutic Radioisotopes

    4 Segmentation of Nuclear Medicine and Radiopharmaceutic Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine and Radiopharmaceutic by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology for Construction

      • 4.4.2 Market Size and Growth Rate of Cardiology for Construction

      • 4.4.3 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Nuclear Medicine and Radiopharmaceutic Production Analysis by Top Regions

    • 5.2 Europe Nuclear Medicine and Radiopharmaceutic Consumption Analysis by Top Regions

    • 5.3 Europe Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.3 France Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    6 Product Circulation of Nuclear Medicine and Radiopharmaceutic Market among Top Countries

    • 6.1 Top 5 Export Countries in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 7.1 Germany Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 7.2 Germany Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    8. UK Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 8.1 UK Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 8.2 UK Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    9. France Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 9.1 France Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 9.2 France Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    10. Italy Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 10.1 Italy Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 10.2 Italy Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    11. Spain Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 11.1 Spain Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 11.2 Spain Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    12. Poland Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 12.1 Poland Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 12.2 Poland Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    13. Russia Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 13.1 Russia Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 13.2 Russia Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    14. Switzerland Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 14.1 Switzerland Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 14.2 Switzerland Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    15. Turkey Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 15.1 Turkey Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 15.2 Turkey Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 16.3.1 Denmark Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 16.3.2 Finland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 16.3.3 Norway Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 16.3.4 Sweden Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 16.3.6 Iceland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 17.3.1 Belgium Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 17.3.2 Netherlands Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 17.3.3 Luxembourg Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Landscape Analysis by Top Countries

      • 18.3.1 Estonia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 18.3.2 Latvia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

      • 18.3.3 Lithuania Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Navidea

      • 19.1.1 Navidea Navidea Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bayer

      • 19.2.1 Bayer Navidea Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Jubilant Pharma

      • 19.3.1 Jubilant Pharma Navidea Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Dongcheng

      • 19.4.1 Dongcheng Navidea Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Nordion

      • 19.5.1 Nordion Navidea Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Lantheus

      • 19.6.1 Lantheus Navidea Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mallinckrodt

      • 19.7.1 Mallinckrodt Navidea Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 IBA Group

      • 19.8.1 IBA Group Navidea Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Eli Lilly

      • 19.9.1 Eli Lilly Navidea Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Triad Isotopes

      • 19.10.1 Triad Isotopes Navidea Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Advanced Accelerator Applications

      • 19.11.1 Advanced Accelerator Applications Navidea Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 GE Healthcare

      • 19.12.1 GE Healthcare Navidea Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 SIEMENS

      • 19.13.1 SIEMENS Navidea Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Company

      • 19.14.1 Company Navidea Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Bracco Imaging

      • 19.15.1 Bracco Imaging Navidea Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 China Isotope & Radiation

      • 19.16.1 China Isotope & Radiation Navidea Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    The List of Tables and Figures (Totals 118 Figures and 187 Tables)

    • Figure Product Picture

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure UK Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure France Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine and Radiopharmaceutic Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine and Radiopharmaceutic

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different Types from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Diagnostic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Therapeutic Radioisotopes Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine and Radiopharmaceutic by Different End-Users from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Cardiology from 2014 to 2026

    • Figure Nuclear Medicine and Radiopharmaceutic Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Nuclear Medicine and Radiopharmaceutic Production by Major Regions

    • Table Europe Nuclear Medicine and Radiopharmaceutic Production Share by Major Regions

    • Figure Europe Nuclear Medicine and Radiopharmaceutic Production Share by Major Countries and Regions in 2014

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption by Major Regions

    • Table Europe Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Regions

    • Table Germany Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table UK Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table France Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Italy Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Spain Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Poland Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Russia Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Switzerland Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Turkey Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Nuclear Medicine and Radiopharmaceutic Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Germany Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Germany Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Germany Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table UK Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table UK Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table UK Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table France Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table France Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table France Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table France Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Italy Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Italy Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Italy Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Spain Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Spain Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Spain Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Poland Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Poland Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Poland Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Russia Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Russia Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Russia Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Switzerland Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Switzerland Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Turkey Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Turkey Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Nuclear Medicine and Radiopharmaceutic Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Nuclear Medicine and Radiopharmaceutic Market Volume and Growth Rate from 2014 to 2026

    • Table Navidea Profiles

    • Table Navidea Production, Value, Price, Gross Margin 2014-2019

    • Table Navidea Product benchmarking

    • Table Navidea Strategic initiatives

    • Table Navidea SWOT analysis

    • Table Bayer Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Product benchmarking

    • Table Bayer Strategic initiatives

    • Table Bayer SWOT analysis

    • Table Jubilant Pharma Profiles

    • Table Jubilant Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Jubilant Pharma Product benchmarking

    • Table Jubilant Pharma Strategic initiatives

    • Table Jubilant Pharma SWOT analysis

    • Table Dongcheng Profiles

    • Table Dongcheng Production, Value, Price, Gross Margin 2014-2019

    • Table Dongcheng Product benchmarking

    • Table Dongcheng Strategic initiatives

    • Table Dongcheng SWOT analysis

    • Table Nordion Profiles

    • Table Nordion Production, Value, Price, Gross Margin 2014-2019

    • Table Nordion Product benchmarking

    • Table Nordion Strategic initiatives

    • Table Nordion SWOT analysis

    • Table Lantheus Profiles

    • Table Lantheus Production, Value, Price, Gross Margin 2014-2019

    • Table Lantheus Product benchmarking

    • Table Lantheus Strategic initiatives

    • Table Lantheus SWOT analysis

    • Table Mallinckrodt Profiles

    • Table Mallinckrodt Production, Value, Price, Gross Margin 2014-2019

    • Table Mallinckrodt Product benchmarking

    • Table Mallinckrodt Strategic initiatives

    • Table Mallinckrodt SWOT analysis

    • Table IBA Group Profiles

    • Table IBA Group Production, Value, Price, Gross Margin 2014-2019

    • Table IBA Group Product benchmarking

    • Table IBA Group Strategic initiatives

    • Table IBA Group SWOT analysis

    • Table Eli Lilly Profiles

    • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Eli Lilly Product benchmarking

    • Table Eli Lilly Strategic initiatives

    • Table Eli Lilly SWOT analysis

    • Table Triad Isotopes Profiles

    • Table Triad Isotopes Production, Value, Price, Gross Margin 2014-2019

    • Table Triad Isotopes Product benchmarking

    • Table Triad Isotopes Strategic initiatives

    • Table Triad Isotopes SWOT analysis

    • Table Advanced Accelerator Applications Profiles

    • Table Advanced Accelerator Applications Production, Value, Price, Gross Margin 2014-2019

    • Table Advanced Accelerator Applications Product benchmarking

    • Table Advanced Accelerator Applications Strategic initiatives

    • Table Advanced Accelerator Applications SWOT analysis

    • Table GE Healthcare Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table GE Healthcare Product benchmarking

    • Table GE Healthcare Strategic initiatives

    • Table GE Healthcare SWOT analysis

    • Table SIEMENS Profiles

    • Table SIEMENS Production, Value, Price, Gross Margin 2014-2019

    • Table SIEMENS Product benchmarking

    • Table SIEMENS Strategic initiatives

    • Table SIEMENS SWOT analysis

    • Table Company Profiles

    • Table Company Production, Value, Price, Gross Margin 2014-2019

    • Table Company Product benchmarking

    • Table Company Strategic initiatives

    • Table Company SWOT analysis

    • Table Bracco Imaging Profiles

    • Table Bracco Imaging Production, Value, Price, Gross Margin 2014-2019

    • Table Bracco Imaging Product benchmarking

    • Table Bracco Imaging Strategic initiatives

    • Table Bracco Imaging SWOT analysis

    • Table China Isotope & Radiation Profiles

    • Table China Isotope & Radiation Production, Value, Price, Gross Margin 2014-2019

    • Table China Isotope & Radiation Product benchmarking

    • Table China Isotope & Radiation Strategic initiatives

    • Table China Isotope & Radiation SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US